AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 48(2), 1993, pp. 193-197
Copyright © 1993 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gordeuk, V. R.
Right arrow Articles by Aikawa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gordeuk, V. R.
Right arrow Articles by Aikawa, M.

Iron Chelation as a Chemotherapeutic Strategy for Falciparum Malaria

Victor R. Gordeuk, Philip E. Thuma, Gary M. Brittenham, Godfrey Biemba, Stenford Zulu, Gracious Simwanza, Peter Kalense, Abraham M'Hango, Dean Parry, A. A. Poltera AND Masamichi Aikawa
MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio; Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania; Macha Mission Hospital, Choma, Zambia, Ciba-Geigy Limited, Basel, Switzerland; Institute of Pathology, Case Western Reserve University, Cleveland, Ohio

To examine the effect of iron chelation against human malaria, 37 Zambians with asymptomatic Plasmodium falciparum infections were randomly assigned to 72-hr infusions of desferrioxamine B or placebo. Mean concentrations of ring forms decreased significantly with desferoxamine B (P < 0.001) but not with a placebo. Over seven days of observation, mean parasite concentrations remained at the initial levels in six individuals originally given placebo, but decreased promptly with administration of desferrioxamine B (P = 0.001). Mean parasitemia was significantly lower for up to four weeks in 16 subjects treated with desferrioxamine B when compared with the eight who had received placebo only (P = 0.027). We conclude that iron chelation has antiplasmodial activity and may offer a new therapeutic strategy for falciparum malaria.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society of Tropical Medicine and Hygiene.